Sumatriptan And Naproxen Sodium Tablet, Film Coated
Product Images NDC 16714-891

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sumatriptan And Naproxen Sodium (NDC 16714-891). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-sumatriptan-and-naproxen-figure1 (Spl Sumatriptan And Naproxen Figure1)

The text describes a graph (Figure 1) that shows the percentage of adult patients who experience relief from initial headache pain within 2 hours of taking Sumatriptan and Naproxen Sodium Tablets 85 mg/ 500 mg, Sumatriptan 85 mg and Naproxen Sodium 500 mg, or a placebo. The graph shows that the combination of Sumatriptan and Naproxen Sodium provided the highest percentage (100%) of headache pain relief within the timeframe. The graph is marked with time points up to 2 hours post-dose.*

FDA Label Image

Spl-sumatriptan-and-naproxen-figure2 (Spl Sumatriptan And Naproxen Figure2)

The text describes a figure showing the probability of adults taking a rescue medication over 24 hours following the first dose. It shows the probability for four different medications: placebo, naproxen, sumatriptan, and sumatriptan and naproxen sodium tablets. The X-axis represents the time in hours postdose, ranging from 6 to 14, and the Y-axis represents the percentage of patients taking a rescue medication.*

FDA Label Image

Spl-sumatriptan-and-naproxen-label (Spl Sumatriptan And Naproxen Label)

This is a pack of Sumatriptan and Naproxen Sodium Tablets with NDC 16714-891-01. The medication guide is provided separately to each patient, and the pack contains 9 tablets. The copyright belongs to NorthStar Healthcare Holdings UC, and the labeling is available upon opening.*

FDA Label Image

Spl-sumatriptan-and-naproxen-naproxen-sodium-str (Spl Sumatriptan And Naproxen Naproxen Sodium Str)

FDA Label Image

Spl-sumatriptan-and-naproxen-sumatriptan-str (Spl Sumatriptan And Naproxen Sumatriptan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.